PALIPalisade BioPALI info
$4.02info-1.47%24h
Global rank26857
Market cap$37.27M
Change 7d13.88%
YTD Performance593.10%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Palisade Bio (PALI) Stock Overview

    Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.

    PALI Stock Information

    Symbol
    PALI
    Address
    7750 El Camino RealCarlsbad, CA 92009United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.palisadebio.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    858 704 4900

    Palisade Bio (PALI) Price Chart

    -
    Value:-

    Palisade Bio Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $4.02
    N/A
    Market Cap
    $37.27M
    N/A
    Shares Outstanding
    9.27M
    N/A
    Employees
    12.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org